{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:26:44Z","timestamp":1794670004784,"version":"4.9.1"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020437","name":"Beijing Association for Science and Technology","doi-asserted-by":"publisher","award":["BYESS2024297"],"award-info":[{"award-number":["BYESS2024297"]}],"id":[{"id":"10.13039\/501100020437","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012173","name":"China-Japan Friendship Hospital","doi-asserted-by":"publisher","award":["2023-NHLHCRF-YXHZ-TJMS-01"],"award-info":[{"award-number":["2023-NHLHCRF-YXHZ-TJMS-01"]}],"id":[{"id":"10.13039\/501100012173","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012173","name":"China-Japan Friendship Hospital","doi-asserted-by":"publisher","award":["2024-NHLHCRF-YXHZ-MS-01"],"award-info":[{"award-number":["2024-NHLHCRF-YXHZ-MS-01"]}],"id":[{"id":"10.13039\/501100012173","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["BUCTRC201912"],"award-info":[{"award-number":["BUCTRC201912"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["PT2403"],"award-info":[{"award-number":["PT2403"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52422316"],"award-info":[{"award-number":["52422316"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52373124"],"award-info":[{"award-number":["52373124"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52221006"],"award-info":[{"award-number":["52221006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52033001"],"award-info":[{"award-number":["52033001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.biomaterials.2025.123730","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:52:38Z","timestamp":1758613958000},"page":"123730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Dual-responsive nanoparticle system for enhanced blood-brain barrier crossing and glioblastoma penetration"],"prefix":"10.1016","volume":"327","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5601-4733","authenticated-orcid":false,"given":"Ziyan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenshan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanyuan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2165-3054","authenticated-orcid":false,"given":"Qingsong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.biomaterials.2025.123730_bib1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.biomaterials.2025.123730_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105780","article-title":"Glioblastoma multiforme (GBM): an overview of current therapies and mechanisms of resistance","volume":"171","author":"Wu","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123730_bib3","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.cell.2023.12.013","article-title":"Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective","volume":"187","author":"Mathur","year":"2024","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123730_bib4","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/neuonc\/noab269","article-title":"Cancer cell heterogeneity and plasticity: a paradigm shift in glioblastoma","volume":"24","author":"Yabo","year":"2021","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.biomaterials.2025.123730_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01402","article-title":"Molecular heterogeneity and immunosuppressive microenvironment in glioblastoma","volume":"11","author":"DeCordova","year":"2020","journal-title":"Front. Immunol."},{"issue":"17","key":"10.1016\/j.biomaterials.2025.123730_bib6","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1001\/jama.2013.280319","article-title":"Glioblastoma and other malignant gliomas: a clinical review","volume":"310","author":"Omuro","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.biomaterials.2025.123730_bib7","series-title":"Handb. Clin. Neurol.","first-page":"381","article-title":"Chapter 23 - glioblastoma","author":"Wirsching","year":"2016"},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123730_bib8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11910-023-01268-0","article-title":"Advances in treatment of isocitrate dehydrogenase (IDH)-wildtype glioblastomas","volume":"23","author":"Sim","year":"2023","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"10.1016\/j.biomaterials.2025.123730_bib9","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.semcancer.2020.12.003","article-title":"Glioblastoma-initiating cell heterogeneity generated by the cell-of-origin, genetic\/epigenetic mutation and microenvironment","volume":"82","author":"Kondo","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"13\u201314","key":"10.1016\/j.biomaterials.2025.123730_bib10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1089\/ten.tea.2021.0168","article-title":"Spatial heterogeneity of invading glioblastoma cells regulated by paracrine factors","volume":"28","author":"Chonan","year":"2022","journal-title":"Tissue Eng."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123730_bib11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s13046-019-1319-4","article-title":"Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12\/CXCR4","volume":"38","author":"Yi","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biomaterials.2025.123730_bib12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mam.2013.06.004","article-title":"Brain tumor stem cells: molecular characteristics and their impact on therapy","volume":"39","author":"Schonberg","year":"2014","journal-title":"Mol. Aspect. Med."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123730_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1838","article-title":"Nanotechnology meets glioblastoma multiforme: emerging therapeutic strategies","volume":"15","author":"Liu","year":"2023","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"issue":"22","key":"10.1016\/j.biomaterials.2025.123730_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202300029","article-title":"Stimuli-responsive multifunctional nanomedicine for enhanced glioblastoma chemotherapy augments multistage blood-to-brain trafficking and tumor targeting","volume":"19","author":"Martins","year":"2023","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123730_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s40824-022-00309-y","article-title":"Efficiently targeted therapy of glioblastoma xenograft via multifunctional biomimetic nanodrugs","volume":"26","author":"Yao","year":"2022","journal-title":"Biomater. Res."},{"issue":"18","key":"10.1016\/j.biomaterials.2025.123730_bib16","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2204621120","article-title":"Self-assembling paclitaxel-mediated stimulation of tumor-associated macrophages for postoperative treatment of glioblastoma","volume":"120","author":"Wang","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123730_bib17","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14528","article-title":"Self-assembled nanoparticles of natural bioactive molecules enhance the delivery and efficacy of paclitaxel in glioblastoma","volume":"30","author":"Li","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123730_bib18","article-title":"Advancements and challenges in brain cancer therapeutics","volume":"4","author":"Bai","year":"2024","journal-title":"Exploration"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123730_bib19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3390\/cancers12010242","article-title":"Nano-therapies for glioblastoma treatment","volume":"12","author":"Alphand\u00e9ry","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.biomaterials.2025.123730_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116913","article-title":"Targeting glioblastoma through nano- and micro-particle-mediated immune modulation","volume":"72","author":"Poot","year":"2022","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123730_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/EXP.20210089","article-title":"Advanced bioactive nanomaterials for biomedical applications","volume":"1","author":"Zhao","year":"2021","journal-title":"Exploration"},{"key":"10.1016\/j.biomaterials.2025.123730_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.116113","article-title":"Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment","volume":"171","author":"Zhao","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biomaterials.2025.123730_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119865","article-title":"Application prospect of peptide-modified nano targeting drug delivery system combined with PD-1\/PD-L1 based immune checkpoint blockade in glioblastoma","volume":"589","author":"Song","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123730_bib24","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3390\/pharmaceutics14081697","article-title":"Nanotechnology-based combinatorial anti-glioblastoma therapies: moving from terminal to treatable","volume":"14","author":"Barzegar Behrooz","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biomaterials.2025.123730_bib25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejpb.2021.08.011","article-title":"Improving temozolomide biopharmaceutical properties in glioblastoma multiforme (GBM) treatment using GBM-targeting nanocarriers","volume":"168","author":"Delello Di Filippo","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biomaterials.2025.123730_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114415","article-title":"Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment","volume":"188","author":"Pandey","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123730_bib27","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s13346-019-00679-2","article-title":"Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme","volume":"10","author":"Jena","year":"2020","journal-title":"Drug Delivery Transl. Res."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123730_bib28","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.drudis.2021.04.008","article-title":"Recent advances in nano delivery systems for blood-brain barrier (BBB) penetration and targeting of brain tumors","volume":"26","author":"Reddy","year":"2021","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123730_bib29","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1124\/jpet.119.257113","article-title":"Pharmacokinetic and pharmacodynamic properties of drug delivery systems","volume":"370","author":"Glassman","year":"2019","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123730_bib30","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123730_bib31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3390\/cancers13020195","article-title":"Nanotechnology and nanocarrier-based drug delivery as the potential therapeutic strategy for glioblastoma multiforme: an update","volume":"13","author":"Hsu","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123730_bib32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3390\/pharmaceutics14020279","article-title":"Transferrin receptor-targeted nanocarriers: overcoming barriers to treat glioblastoma","volume":"14","author":"Ramalho","year":"2022","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.biomaterials.2025.123730_bib33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.bcp.2006.08.010","article-title":"Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors","volume":"73","author":"Hogg","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.biomaterials.2025.123730_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105336","article-title":"Choline and nicotine increase glioblastoma cell proliferation by binding and activating \u03b17- and \u03b19- containing nicotinic receptors","volume":"163","author":"Pucci","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123730_bib35","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/nbm.1377","article-title":"1H HR-MAS and genomic analysis of human tumor biopsies discriminate between high and low grade astrocytomas","volume":"22","author":"Righi","year":"2009","journal-title":"NMR Biomed."},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123730_bib36","doi-asserted-by":"crossref","first-page":"7006","DOI":"10.1038\/s41467-021-27348-8","article-title":"Nicotine-mediated OTUD3 downregulation inhibits VEGF-C mRNA decay to promote lymphatic metastasis of human esophageal cancer","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"issue":"19","key":"10.1016\/j.biomaterials.2025.123730_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914570","article-title":"Nicotine: from discovery to biological effects","volume":"24","author":"Sansone","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.biomaterials.2025.123730_bib38","doi-asserted-by":"crossref","first-page":"8197","DOI":"10.7150\/thno.58947","article-title":"Early administration of MPC-n(IVIg) selectively accumulates in ischemic areas to protect inflammation-induced brain damage from ischemic stroke","volume":"11","author":"Jin","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.biomaterials.2025.123730_bib39","first-page":"578","article-title":"Nanomotor-based H2S donor with mitochondrial targeting function for treatment of Parkinson's disease","volume":"31","author":"Zhao","year":"2024","journal-title":"Bioact. Mater."},{"issue":"18","key":"10.1016\/j.biomaterials.2025.123730_bib40","article-title":"A bioinspired platform for effective delivery of protein therapeutics to the central nervous system","volume":"31","author":"Wu","year":"2019","journal-title":"Adv. Mater."},{"issue":"33","key":"10.1016\/j.biomaterials.2025.123730_bib41","article-title":"Efficient delivery of nerve growth factors to the central nervous system for neural regeneration","volume":"31","author":"Xu","year":"2019","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123730_bib42","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11095-024-03670-w","article-title":"Acetylcholine analog-modified albumin nanoparticles for the enhanced and synchronous brain delivery of saponin components of panax notoginseng","volume":"41","author":"Yu","year":"2024","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biomaterials.2025.123730_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121305","article-title":"Cascade-responsive nano-assembly for efficient photothermal-chemo synergistic inhibition of tumor metastasis by targeting cancer stem cells","volume":"280","author":"Zhu","year":"2022","journal-title":"Biomaterials"},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123730_bib44","first-page":"845","article-title":"The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells","volume":"46","author":"van Furth","year":"1972","journal-title":"Bull. W. H. O."},{"issue":"16","key":"10.1016\/j.biomaterials.2025.123730_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202009942","article-title":"Dye-sensitized downconversion nanoprobes with emission beyond 1500 nm for ratiometric visualization of cancer redox state","volume":"31","author":"Wang","year":"2021","journal-title":"Adv. Funct. Mater."},{"issue":"8","key":"10.1016\/j.biomaterials.2025.123730_bib46","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/BF02236562","article-title":"Relationship between colorectal cancer glutathione levels and patient survival: early results","volume":"43","author":"Barranco","year":"2000","journal-title":"Dis. Colon Rectum"},{"issue":"50","key":"10.1016\/j.biomaterials.2025.123730_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202303403","article-title":"A purposefully designed pH\/GSH-responsive MnFe-based metal-organic frameworks as cascade nanoreactor for enhanced chemo-chemodynamic-starvation synergistic therapy","volume":"19","author":"Chen","year":"2023","journal-title":"Small"},{"issue":"1","key":"10.1016\/j.biomaterials.2025.123730_bib48","doi-asserted-by":"crossref","first-page":"168","DOI":"10.14336\/AD.2024.0206-1","article-title":"Nanomaterials in medicine: understanding cellular uptake, localization, and retention for enhanced disease diagnosis and therapy","volume":"16","author":"Peng","year":"2025","journal-title":"Aging Dis"},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123730_bib49","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41565-021-00858-8","article-title":"Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics","volume":"16","author":"Rennick","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"5","key":"10.1016\/j.biomaterials.2025.123730_bib50","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3390\/nano12050743","article-title":"Recent advancements in mitochondria-targeted nanoparticle drug delivery for cancer therapy","volume":"12","author":"Xu","year":"2022","journal-title":"Nanomaterials"},{"key":"10.1016\/j.biomaterials.2025.123730_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.786621","article-title":"Multifunctional mitochondria-targeting nanosystems for enhanced anticancer efficacy","volume":"9","author":"Hu","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"2","key":"10.1016\/j.biomaterials.2025.123730_bib52","first-page":"116","article-title":"Mitochondria and apoptosis","volume":"31","author":"Lin","year":"1999","journal-title":"Acta Biochim. Biophys. Sin."},{"issue":"1\u20132","key":"10.1016\/j.biomaterials.2025.123730_bib53","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0022-1759(02)00069-8","article-title":"Quantitation of mitochondrial alterations associated with apoptosis","volume":"265","author":"Castedo","year":"2002","journal-title":"J. Immunol. Methods"},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123730_bib54","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.3390\/pharmaceutics12111013","article-title":"Overcoming the blood-brain barrier: functionalised chitosan nanocarriers","volume":"12","author":"Caprifico","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biomaterials.2025.123730_bib55","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.addr.2020.10.001","article-title":"Designing peptide nanoparticles for efficient brain delivery","volume":"160","author":"Duro-Castano","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2025.123730_bib56","first-page":"2041","article-title":"Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA","volume":"8","author":"Malhotra","year":"2013","journal-title":"Int. J. Nanomed."},{"issue":"19","key":"10.1016\/j.biomaterials.2025.123730_bib57","article-title":"Systemic delivery of monoclonal antibodies to the central nervous system for brain tumor therapy","volume":"31","author":"Han","year":"2019","journal-title":"Adv. Mater."},{"issue":"3","key":"10.1016\/j.biomaterials.2025.123730_bib58","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1254\/jjp.25.354","article-title":"Direct inhibitory effect of hemicholinium-No. 3 on acetylcholine release","volume":"25","author":"Hata","year":"1975","journal-title":"Jpn. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.biomaterials.2025.123730_bib59","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1021\/acs.nanolett.3c00449","article-title":"Role of micelle size in cell transcytosis-based tumor extravasation, infiltration, and treatment efficacy","volume":"23","author":"Fan","year":"2023","journal-title":"Nano Lett."},{"issue":"7","key":"10.1016\/j.biomaterials.2025.123730_bib60","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2215308120","article-title":"Dendrimer nanosystems for adaptive tumor-assisted drug delivery via extracellular vesicle hijacking","volume":"120","author":"Jiang","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"31","key":"10.1016\/j.biomaterials.2025.123730_bib61","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202202834","article-title":"Deep-penetrating triple-responsive prodrug nanosensitizer actuates efficient chemoradiotherapy in pancreatic ductal adenocarcinoma models","volume":"18","author":"Tang","year":"2022","journal-title":"Small"},{"issue":"11","key":"10.1016\/j.biomaterials.2025.123730_bib62","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.0631766100","article-title":"Exo1: a new chemical inhibitor of the exocytic pathway","volume":"100","author":"Feng","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"29","key":"10.1016\/j.biomaterials.2025.123730_bib63","doi-asserted-by":"crossref","first-page":"11742","DOI":"10.1021\/acs.analchem.4c01097","article-title":"Hypersensitive MR angiography for diagnosis of ischemic stroke and reperfusion subarachnoid hemorrhage","volume":"96","author":"Zhang","year":"2024","journal-title":"Anal. Chem."},{"issue":"6","key":"10.1016\/j.biomaterials.2025.123730_bib64","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.3390\/cancers15061919","article-title":"Mismatch between bioluminescence imaging (BLI) and MRI when evaluating glioblastoma growth: lessons from a study where BLI suggested \u201cregression\u201d while MRI showed \u201cprogression\u201d","volume":"15","author":"Bausart","year":"2023","journal-title":"Cancers (Basel)"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225006490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225006490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:03:08Z","timestamp":1780477388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961225006490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":64,"alternative-id":["S0142961225006490"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123730","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dual-responsive nanoparticle system for enhanced blood-brain barrier crossing and glioblastoma penetration","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123730","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123730"}}